# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-23-016299
Filing Date
2023-05-01
Accepted
2023-05-01 16:47:59
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | 2023_-_proxy-_defa_14a.htm | DEFA14A | 29419
2 | GRAPHIC | img101995081_0.jpg | GRAPHIC | 715213
3 | GRAPHIC | img101995081_1.jpg | GRAPHIC | 277995
| Complete submission text file | 0000950170-23-016299.txt |  | 1397742

Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36620 | Film No.: 23874539
SIC: 2834 Pharmaceutical Preparations